Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis
Open Access
- 1 April 2000
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/hemostasis
- Vol. 6 (2) , 100-103
- https://doi.org/10.1177/107602960000600210
Abstract
Before hemodialysis (HD), plasma levels of tissue factor (TF), free-TF pathway inhibitor (TFPI) and thrombo modulin (TM) were significantly higher in patients with HD than in healthy volunteers. Plasma levels of (T-F) TFPI and plasmin plasmin inhibitor complex (PPIC) were significantly higher in patients with HD than in healthy volunteers. During HD, plasma levels of TF and (T-F) TFPI were not significantly increased, but plasma levels of total TFPI and free TFPI at 1 hour after and at the end of HD were significantly increased, compared with levels before start of HD. Plasma level of PPIC 1 hour after start of HD was significantly higher than before start of HD, and plasma levels of thrombin antithrombin com plex (TAT). PPIC. D-dimer. TM, and protein C (PC) at the end of HD were significantly higher than before start of HD. In patients with thrombosis complications, plasma TF levels were significantly higher than in patients without thrombotic com plications during HD. Plasma levels of PC were significantly lower in patients with thrombotic complications than in patients without thrombotic complications. There was no significant difference between both groups during HD in hemostatic pa rameters, with the exception of TF and PC. Hemostatic abnormalities existed in patients with HD; espe cially, increased TF and decreased PC might cause thrombotic complications.Keywords
This publication has 23 references indexed in Scilit:
- Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuriesAmerican Journal of Hematology, 1998
- Measurement of the Free Form of TFPI Antigen in HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysisBlood Coagulation & Fibrinolysis, 1994
- Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapyThrombosis Research, 1990
- Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemiaThrombosis Research, 1988
- The Regulation of Natural Anticoagulant PathwaysScience, 1987
- Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.Proceedings of the National Academy of Sciences, 1986
- Congenital Protein C Deficiency and Venous ThromboembolismNew England Journal of Medicine, 1983
- Cultured human endothelial cells generate tissue factor in response to endotoxin.Journal of Clinical Investigation, 1983
- Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells.Journal of Clinical Investigation, 1977